Nasdaq debutante Septerna swells its IPO to $331m

Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount raised topping $331 million.

AbbVie taps Sosei Heptares GPCR expertise with $1.2bn+ allia...

Sosei Heptares has signed up a string of big pharma collaborators over the last few years, and one of them – AbbVie – has just expanded its partnership with a new to deal to apply the biote

UK biotech OMass raises £27.5m for GPCR drug discovery

Sosei Heptares bags another big partnership, this time with ...

Pfizer selects first GPCR candidate from Sosei Heptares tie-...

Pfizer has selected the first drug candidate from a collaboration with Sosei Group to develop drugs for major diseases, which are aimed at targets from the G protein-coupled receptor (GPCR)